About Clinical Trial Management System (CTMS)
Clinical trials are defined as research studies undertaken to successfully test a drug or a medical device before launching the product in the market. These studies are pivotal as the data generated in these studies forms the basis for the approval process of a drug or a medical device. Typically, these clinical trials are divided into five phases with each phase as critical as any other. It takes approximately 12 years to successfully complete a clinical trial, and the typical cost estimate of a clinical trial is $800 million to $1.2 billion with a success rate of 12% that the drug will get approved in the market or not.
Technavio’s analysts forecast the global clinical trial management system (CTMS) market to grow at a CAGR of 12.98% during the period 2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global clinical trial management system (CTMS) market for 2017-2021 . To calculate the market size, the report considers the revenue generated from the retail sales of CTMS components that comprise software and services.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Clinical Trial Management System (CTMS) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Bioclinica
• Medidata
• Oracle
• PAREXEL
Other prominent vendors
• ArisGlobal
• Bio-Optronics
• DATATRAK
• DSG
• ERT Clinical
• FORTE
• MedNet Solutions
• Merge
• Trial By Fire Solutions
• Veeva Systems
Market driver
• Increase in R&D expenditure
• For a full, detailed list, view our report
Market challenge
• Rising cost of clinical trials
• For a full, detailed list, view our report
Market trend
• Increasing outsourcing of clinical trial process
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
• Market outline
PART 05: MARKET LANDSCAPE
• Market size and forecast
• Five forces analysis
PART 06: MARKET SEGMENTATION BY END-USERS
• Global CTMS market by end-users
• Global CTMS market by pharmaceutical and biotechnology companies
• Global CTMS market by CROs
• Global CTMS market by others
PART 07: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast
• EMEA – Market size and forecast
• APAC – Market size and forecast
• Key leading countries
• Market opportunity
PART 08: DECISION FRAMEWORK
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Increasing outsourcing of clinical trial process
• Integration of CTMS with other systems
• Adoption of cloud computing
PART 11: VENDOR LANDSCAPE
• Competitive scenario
• Investment opportunity
PART 12: KEY VENDOR ANALYSIS
• Bioclinica
• Medidata
• Oracle
• PAREXEL
• Other prominent vendors
PART 13: APPENDIX
• List of abbreviations
List of Exhibits?
Exhibit 01: Various phases in a clinical trial
Exhibit 02: Advantage of CTMS
Exhibit 03: Global CTMS market: Market overview
Exhibit 04: Global CTMS market 2016-2021 ($ millions)
Exhibit 05: Factors impacting the global CTMS market
Exhibit 06: Five forces analysis
Exhibit 07: Global CTMS market by end-users 2016-2021 (% share)
Exhibit 08: Global CTMS market by end-users: Snapshot
Exhibit 09: Global CTMS market by pharmaceutical and biotechnology companies 2016-2021 ($ millions)
Exhibit 10: Global CTMS market by CROs 2016-2021 ($ millions)
Exhibit 11: Advantage of using CTMS in retrieving data from CROs
Exhibit 12: Leading CROs with internally developed CTMS systems
Exhibit 13: Global CTMS market by others 2016-2021 ($ millions)
Exhibit 14: Global CTMS market by geography 2016-2021 (% share)
Exhibit 15: Regional comparison
Exhibit 16: Americas – Market size and forecast 2016-2021 ($ millions)
Exhibit 17: Americas – Year-over-year growth
Exhibit 18: EMEA – Market size and forecast 2016-2021 ($ millions)
Exhibit 19: EMEA – Year-over-year growth
Exhibit 20: APAC – Market size and forecast 2016-2021 ($ millions)
Exhibit 21: APAC – Year-over-year growth
Exhibit 22: Key leading countries
Exhibit 23: Strategic success factors for vendors
Exhibit 24: Investment opportunity mapping
Exhibit 25: Bioclinica: Profile
Exhibit 26: Bioclinica: Strength analysis
Exhibit 27: Bioclinica: Strategy assessment
Exhibit 28: Bioclinica: Opportunity assessment
Exhibit 29: Medidata: Profile
Exhibit 30: Medidata: Strength analysis
Exhibit 31: Medidata strategy assessment
Exhibit 32: Medidata: Opportunity assessment
Exhibit 33: Oracle: Profile
Exhibit 34: Oracle: Strength analysis
Exhibit 35: Oracle: Strategy assessment
Exhibit 36: Oracle: Opportunity assessment
Exhibit 37: PAREXEL: Profile
Exhibit 38: PAREXEL: Strength analysis
Exhibit 39: PAREXEL: Strategy assessment
Exhibit 40: PAREXEL: Opportunity assessment
